FDA approves pill with digital tracking device you swallow
Abilify MyCite, a form of aripiprazole and a first-of-its-kind product, has an embedded ingestible sensor that records when the medication is taken. Made by Japan-based Otsuka Pharmaceutical Co., the medication system is intended to treat schizophrenia, bipolar I disorder and depression in adults. Abilify without sensor technology was first approved to treat schizophrenia in 2002.
Schizophrenia, a psychotic disorder, includes symptoms of delusions and hallucinations. Bipolar patients may experience alternating episodes of mania and depression, a persistent sadness.
Peter Sobat is the owner/creator of Blurred Culture. Peter holds a MFA in Digital Technology and has worked in media for the past 15 years. He is the creator of several viral hits such as "The SmokeBox" , "The Devin The Dude Show" and "Live with Steve Lobel".